Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MHCR-1
- Development stage
- Preclinical
- Lead developer
- Odacova Health
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
MHCR-1 is a proprietary, botanical-derived bioactive ingredient developed by Odacova Health as a calorie restriction mimetic (CRM) for companion animals. Grounded in calorie-restriction-mimetic research and metabolic signaling, MHCR-1 is designed to translate the health and longevity benefits of calorie restriction into a practical healthy-aging platform for dogs without requiring reduced caloric intake. In a nine-year longitudinal canine research program, MHCR-1 demonstrated the ability to shift age-associated gene-expression patterns toward younger profiles, improve age-related fasting glucose trajectories, and preserve cumulative muscle power over time.
Beyond the preview
Go deeper on MHCR-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MHCR-1.